The British government has fired the starting gun on a plan to sell its stake in Europe’s largest city-centre redevelopment project around London’s King’s Cross station, in its latest disposal aimed at boosting state coffers.

An Irish biotechnology company developing drugs to tackle a heart disease that causes sudden death in young athletes has raised $20m (€14.5m) Series A financing for clinical drug trials.